Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead
Frontiers in Psychiatry November 4, 2021 M.l. Williams, Diana Korevaar, Renee Harvey et al. 23 citations
After a 40-year research hiatus due to sociopolitical issues, psychedelic-assisted therapies are being reinvestigated for mental illness. Clinicians and researchers in Australia identified five categories of challenge to moving these therapies from clinical trials to community practice: inherent risks, poor clinical practice, inadequate infrastructure, problematic perceptions, and divisive relationships. They propose strategies including public-sector support for research and training to establish best practices, funding for equitable access, and a multidisciplinary advisory body to guide policy. While framed in Australia, the challenges and strategies may apply elsewhere.